CareDx - 10 Year Stock Price History | CDNA
Historical daily share price chart and data for CareDx since 2014 adjusted for splits and dividends. The latest closing stock price for CareDx as of December 24, 2024 is 21.42.
- The all-time high CareDx stock closing price was 95.60 on January 20, 2021.
- The CareDx 52-week high stock price is 34.84, which is 62.7% above the current share price.
- The CareDx 52-week low stock price is 7.42, which is 65.4% below the current share price.
- The average CareDx stock price for the last 52 weeks is 17.86.
| CareDx Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 17.8854 | 11.9400 | 33.9900 | 7.5600 | 21.4200 | 78.50% |
| 2023 | 9.6327 | 11.1000 | 17.6100 | 4.9000 | 12.0000 | 5.17% |
| 2022 | 25.6693 | 46.6000 | 46.6000 | 10.8800 | 11.4100 | -74.91% |
| 2021 | 71.2634 | 71.4900 | 95.6000 | 41.2000 | 45.4800 | -37.23% |
| 2020 | 35.7752 | 21.1500 | 77.0900 | 13.9400 | 72.4500 | 235.88% |
| 2019 | 27.9135 | 23.9800 | 40.0800 | 19.2400 | 21.5700 | -14.20% |
| 2018 | 15.5675 | 7.0500 | 30.0200 | 5.1800 | 25.1400 | 242.51% |
| 2017 | 2.9090 | 2.3000 | 7.3700 | 0.7857 | 7.3400 | 171.85% |
| 2016 | 4.4480 | 6.2700 | 6.3300 | 2.6500 | 2.7000 | -57.81% |
| 2015 | 6.0152 | 7.2250 | 7.6700 | 4.1100 | 6.4000 | -11.72% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.105B | $0.280B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $84.874B | 10.53 |
| Cencora (COR) | United States | $44.008B | 16.55 |
| DiDi Global (DIDIY) | China | $22.650B | 0.00 |
| Natera (NTRA) | United States | $21.372B | 0.00 |
| ICON (ICLR) | Ireland | $17.119B | 15.25 |
| Viatris (VTRS) | United States | $14.944B | 4.60 |
| Avantor (AVTR) | United States | $14.436B | 21.64 |
| Revvity (RVTY) | United States | $13.699B | 23.80 |
| BioMerieux (BMXMF) | France | $12.615B | 0.00 |
| CochLear (CHEOY) | Australia | $11.851B | 0.00 |
| Solventum (SOLV) | United States | $11.545B | 0.00 |
| Doximity (DOCS) | United States | $10.796B | 63.55 |
| Medpace Holdings (MEDP) | United States | $10.483B | 29.53 |
| Charles River Laboratories (CRL) | United States | $9.500B | 18.36 |
| HealthEquity (HQY) | United States | $8.229B | 41.28 |
| Sonic Healthcare (SKHHY) | Australia | $8.181B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.339B | 29.51 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Organon (OGN) | United States | $3.755B | 3.79 |
| Sotera Health (SHC) | United States | $3.750B | 20.06 |
| BrightSpring Health Services (BTSG) | United States | $3.007B | 63.96 |
| Surgery Partners (SGRY) | United States | $2.697B | 30.75 |
| Concentras Parent (CON) | United States | $2.551B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.285B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.126B | 0.00 |
| Premier (PINC) | United States | $2.091B | 10.88 |
| Alignment Healthcare (ALHC) | United States | $2.034B | 0.00 |
| PACS (PACS) | United States | $1.983B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.692B | 44.40 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.651B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.625B | 0.00 |
| Progyny (PGNY) | United States | $1.221B | 24.72 |
| Pediatrix Medical (MD) | United States | $1.210B | 11.84 |
| Embecta (EMBC) | United States | $1.176B | 8.22 |
| Establishment Labs Holdings (ESTA) | $1.120B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.873B | 5.91 |
| Agilon Health (AGL) | United States | $0.812B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| SBC Medicals (SBC) | United States | $0.622B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.568B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.501B | 0.00 |
| DocGo (DCGO) | United States | $0.460B | 17.35 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| Enhabit (EHAB) | United States | $0.385B | 33.26 |
| Sera Prognostics (SERA) | United States | $0.297B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.272B | 0.00 |
| Biodesix (BDSX) | United States | $0.228B | 0.00 |
| LifeMD (LFMD) | United States | $0.218B | 0.00 |
| Beauty Health (SKIN) | United States | $0.181B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| ModivCare (MODV) | United States | $0.159B | 8.63 |
| MultiPlan (MPLN) | United States | $0.097B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.092B | 0.00 |
| So-Young (SY) | China | $0.091B | 15.40 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeueHealth (NEUE) | United States | $0.032B | 0.84 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |